DANA HOWARD: Open Payments
NPI 1760925598 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 9 payments from 7 companies in 2025. Trend: 2023 $76 · 2024 $347 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Dexcom, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, Dexcom G6 Transmitter, INSPIRE, Kerendia, Ozempic, XIFAXAN, FARXIGA.
Industry payments across AR — which companies pay providers there.
